These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34849990)

  • 1. HPLC-MS Analysis of Four Potential Genotoxic Impurities in Alogliptin Pharmaceutical Materials.
    Al-Sabti B; Harbali J
    J AOAC Int; 2022 Mar; 105(2):362-369. PubMed ID: 34849990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of an analytical method for quantitative determination of three potentially genotoxic impurities in vildagliptin drug material using HPLC-MS.
    Al-Sabti B; Harbali J
    J Sep Sci; 2021 Jul; 44(13):2587-2595. PubMed ID: 33934507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Determination of Four Potential Genotoxic Impurities in the Active Pharmaceutical Ingredients in TSD-1 Using UPLC-MS/MS.
    Wang T; Yang H; Yang J; Guo N; Wu G; Xu X; An M
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study between UHPLC-UV and UPLC-MS/MS methods for determination of alogliptin and metformin in their pharmaceutical combination.
    Mowaka S; Ayoub BM
    Pharmazie; 2017 Feb; 72(2):67-72. PubMed ID: 29441855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple and sensitive LC-MS/MS method for determination and quantification of potential genotoxic impurities in the ceritinib active pharmaceutical ingredient.
    Antolčić M; Runje M; Galić N
    Anal Methods; 2020 Jul; 12(25):3290-3295. PubMed ID: 32930193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of
    Guo C; Liu Q; Zhang L; Zheng J; Wang Y; Yang S; Chu Z; Niu C; Xu Y
    Se Pu; 2020 Nov; 38(11):1288-1293. PubMed ID: 34213099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous and trace level quantification of two potential genotoxic impurities in valsartan drug substance using UPLC-MS/MS.
    Li S; Dong L; Tang K; Lan Z; Liu R; Wang Y; Wang R; Lin H
    J Pharm Biomed Anal; 2022 Apr; 212():114630. PubMed ID: 35158183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trace-level determination of potential genotoxic impurities in quetiapine fumarate using LC-MS.
    Kavitapu D; Gopireddy RR; Maruthapillai A; Murty JNSRC; Katari NK
    Biomed Chromatogr; 2023 Apr; 37(4):e5575. PubMed ID: 36541925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high-performance liquid chromatography-tandem mass spectrometry method for simultaneous determination of imigliptin, its five metabolites and alogliptin in human plasma and urine and its application to a multiple-dose pharmacokinetic study.
    Liu Y; Song L; Yao X; Wu Y; Liu H; Zhao Q; Jiang J; Shi C; Ma X; Zhou H; Liu D; Hu P
    Biomed Chromatogr; 2018 Nov; 32(11):e4324. PubMed ID: 29952007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.
    A VBR; Yusop Z; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J
    J Pharm Biomed Anal; 2016 Sep; 128():141-148. PubMed ID: 27262107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of chromatographic methods for the determination of genotoxic impurities in cloperastine fendizoate.
    García A; Rupérez FJ; Ceppa F; Pellati F; Barbas C
    J Pharm Biomed Anal; 2012 Mar; 61():230-6. PubMed ID: 22226040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of related substances in alogliptin benzoate by LC-QTOF mass spectrometric techniques.
    Lu Y; Yang D; Li Z; Hang T; Song M
    J Pharm Biomed Anal; 2016 Sep; 128():253-263. PubMed ID: 27281581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of potential genotoxic impurities in rabeprazole active pharmaceutical ingredient via Liquid Chromatography-tandem Mass Spectrometry, following quality-by-design principles for method development.
    Iliou K; Malenović A; Loukas YL; Dotsikas Y
    J Pharm Biomed Anal; 2018 Feb; 149():410-418. PubMed ID: 29154196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced LC-MS/MS analysis of alogliptin and pioglitazone in human plasma: Applied to a preliminary pharmacokinetic study.
    Abdel-Ghany MF; Ayad MF; Tadros MM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jul; 1058():93-101. PubMed ID: 28528664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of pioglitazone, its metabolite and alogliptin in human plasma by a novel LC-MS/MS method; application to a pharmacokinetic study.
    Kelani KM; Rezk MR; Badran OM; Elghobashy MR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Nov; 1132():121803. PubMed ID: 31704620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of process-related impurities including forced degradation products of alogliptin benzoate and the development of the corresponding reversed-phase high-performance liquid chromatography method.
    Zhou Y; Zhou W; Sun L; Zou Q; Wei P; OuYang P
    J Sep Sci; 2014 Jun; 37(11):1248-55. PubMed ID: 24616424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selective and sensitive UPLC-MS/MS approach for trace level quantification of four potential genotoxic impurities in zolmitriptan drug substance.
    Vijaya Bhaskar Reddy A; Venugopal N; Madhavi G; Gangadhara Reddy K; Madhavi V
    J Pharm Biomed Anal; 2013 Oct; 84():84-9. PubMed ID: 23816589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A validated LC-MS/MS method for simultaneous determination of linagliptin and metformin in spiked human plasma coupled with solid phase extraction: Application to a pharmacokinetic study in healthy volunteers.
    Abbas Moussa B; Mahrouse MA; Fawzy MG
    J Pharm Biomed Anal; 2019 Jan; 163():153-161. PubMed ID: 30312887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validated HPLC-MS/MS method for quantification of ethylmethylhydroxypyridine succinate in rat brain and its application to a pharmacokinetic study.
    Melnik EV; Petukhov AE; Kozin SV; Pomerantseva TY; Ramenskaya GV
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Oct; 1096():180-186. PubMed ID: 30176507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.